Pancreatic function, quality of life and costs at long-term follow-up after acute pancreatitis

Table 3 Endocrine parameters in patients classified as having diabetes according to the World Health Organization definition and patients not fulfilling the criteria

Parameter	Diabetic patients (n = 9)	Non-diabetic patients (n = 30)	Difference between groups (P)
Fasting plasma glucose, 0 min1	6.9 (6.0-7.3)	5.1 (4.6-5.5)	< 0.001
Plasma glucose 120 min1	13 (12-14)	6.8 (5.5-8.2)	< 0.001
Plasma C-peptide 0 min2	1.7 (1.3-2)	0.72 (0.6-1.0)	< 0.001
Plasma C-peptide 120 min2	4.8 (4.1-5.9)	2.9 (2.2-4.4)	0.024
Serum insulin 0 min3	16 (13-17)	6 (4-9)	0.001
Serum insulin 120 min3	103 (79-126)	42 (28-60)	0.001
HOMA-insulin resistance	4.2 (3.7-5.4)	1.3 (0.9-2.2)	< 0.001
HBA1c	5.3 (5.0- 5.6)	4.6 (4.5-4.8)	< 0.001

¹mmol/L;

²nmol/L;

³mIE/L; Values are given in median (interquartile range). HOMA: Homeostasis model assessment; HBA1c: Fasting glycosylated hemoglobin.